Third Hospital of Peking University Trials

Third Hospital of Peking University	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Song, Hongmei

BRRPJS, NCT06410833: Belimumab After Rituximab in Resistant Primary Juvenile SS

Recruiting

RoW

Rituximab, Belimumab

Peking Union Medical College Hospital, Children's Hospital of Chongqing Medical University, Central South University, Shenzhen Children's Hospital, The First Hospital of Jilin University, Children's Hospital of The Capital Institute of Pediatrics, The Affiliated Hospital of Qingdao University, Children's Hospital of Nanjing Medical University, Children's Hospital of Fudan University, Shengjing Hospital, Shanghai Children's Hospital, Tianjin Children's Hospital

Sjogren's Syndrome, Pediatric ALL

12/25

12/26

NCT03923140: A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)

Recruiting

RoW

Tranilast, Rizaben

Peking Union Medical College Hospital

Cryopyrin-Associated Periodic Syndromes

04/24

10/24

NCT05687526: A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus

Recruiting

RoW

Telitacicept, RC18

RemeGen Co., Ltd.

Systemic Lupus Erythematosus

09/25

10/25

NCT06417502: Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

Recruiting

N/A

20000

RoW

Peking Union Medical College Hospital, Children's Hospital of Chongqing Medical University, Central South University, Beijing Children's Hospital, Shenzhen Children's Hospital, Children's Hospital of Nanjing Medical University, The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Zhejiang University, Third Hospital of Peking University

Autoimmune Diseases, Autoinflammatory Diseases

11/24

12/31



	Diseases Companies Products Productz Mechanisms of Action Sites